CAIP awards $10.9 million to CDRD and CVI

Guest Contributor
November 27, 2014

The Centre for Drug Research and Development (CDRD) and its commercialization arm — CDRD Ventures Inc — have received $10.9 million from the Canada Accelerator and Incubator Program (CAIP). CDRD will use the funding to incubate firms by helping to de-risking discoveries derived from publicly funded health research and making early-stage research more investment ready. CVI will act as an accelerator, selecting the most promising discoveries and helping to advance the technologies to the point of licensing, co-development or the basis of a spin-off company. CDRD has evaluated more than 1,000 technologies since becoming fully operational in 2008....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.